{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Anti-SARS-CoV-2 antibody",
      "Coronavirus disease-2019",
      "Lateral flow immunoassay",
      "Point-of-care",
      "Real-time reverse transcription PCR"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32513617",
  "DateCompleted": {
    "Year": "2021",
    "Month": "04",
    "Day": "29"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "04",
    "Day": "29"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "06",
        "Day": "05"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.jmii.2020.05.016",
      "S1684-1182(20)30140-7"
    ],
    "Journal": {
      "ISSN": "1995-9133",
      "JournalIssue": {
        "Volume": "54",
        "Issue": "2",
        "PubDate": {
          "Year": "2021",
          "Month": "Apr"
        }
      },
      "Title": "Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi",
      "ISOAbbreviation": "J Microbiol Immunol Infect"
    },
    "ArticleTitle": "In\u00a0vitro diagnostics of coronavirus disease 2019: Technologies and application.",
    "Pagination": {
      "StartPage": "164",
      "EndPage": "174",
      "MedlinePgn": "164-174"
    },
    "Abstract": {
      "AbstractText": [
        "Laboratory-based diagnostic measures including virological and serological tests are essential for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Real-time reverse transcription-polymerase chain reactions (rRT-PCR) can detect SARS-COV-2 by targeting open reading frame-1 antibodies (ORF1ab), envelope protein, nucleocapsid protein, RNA-dependent RNA polymerase genes, and the N1, N2, and N3 (3N) target genes. Therefore, rRT-PCR remains the primary method of diagnosing SARS-CoV-2 despite being limited by false-negative results, long turnaround, complex protocols, and a need for skilled personnel. Serological diagnosis of coronavirus disease 2019 (COVID-19) is simple and does not require complex techniques and equipment, rendering it suitable for rapid detection and massive screening. However, serological tests cannot confirm SARS-CoV-2, and results will be false-negative when antibody concentrations fall below detection limits. Balancing the increased use of laboratory tests, risk of testing errors, need for tests, burden on healthcare systems, benefits of early diagnosis, and risk of unnecessary exposure is a significant and persistent challenge in diagnosing COVID-19."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021. Published by Elsevier B.V."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan, Taiwan."
          }
        ],
        "LastName": "Lai",
        "ForeName": "Chih-Cheng",
        "Initials": "CC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan."
          }
        ],
        "LastName": "Wang",
        "ForeName": "Cheng-Yi",
        "Initials": "CY"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan."
          }
        ],
        "LastName": "Ko",
        "ForeName": "Wen-Chien",
        "Initials": "WC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hsporen@ntu.edu.tw."
          }
        ],
        "LastName": "Hsueh",
        "ForeName": "Po-Ren",
        "Initials": "PR"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Microbiol Immunol Infect",
    "NlmUniqueID": "100956211",
    "ISSNLinking": "1684-1182"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "diagnosis",
        "immunology",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "methods",
        "statistics & numerical data"
      ],
      "DescriptorName": "COVID-19 Nucleic Acid Testing"
    },
    {
      "QualifierName": [
        "methods",
        "statistics & numerical data"
      ],
      "DescriptorName": "COVID-19 Serological Testing"
    },
    {
      "QualifierName": [
        "methods",
        "statistics & numerical data"
      ],
      "DescriptorName": "COVID-19 Testing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "False Negative Reactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "False Positive Reactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "In Vitro Techniques"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "genetics",
        "immunology",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sensitivity and Specificity"
    }
  ],
  "CoiStatement": "Declaration of Competing Interest The authors declare that they have no conflicts of interest."
}